Genome-Scale Metabolic Models have shown promising results in biomedical applications, such as understanding cancer metabolism and drug discovery. However, to take full advantage of these models there is the need to address the representation and simulation of the metabolic phenotypes of distinct cell types. With this aim, several algorithms have been recently proposed to reconstruct tissue-specific metabolic models based on available data. Here, the most promising were implemented and used to reconstruct models for two case studies, using omics data from distinct sources. The set of obtained models were compared and analyzed, being shown they are highly variable and that no combination of algorithm and data source can achieve models with acceptable phenotype predictions. We propose an algorithm to achieve a consensus model from the set of models available for a given tissue/cell line, and to improve it given functional data (e.g. known metabolic tasks). The results show that the resulting models are more accurate, both considering the prediction of known metabolic phenotypes and of experimental data not used in the model construction. Two case studies used for model validation consider healthy hepatocytes and a glioblastoma cell line. The open-source implementation of the algorithms is provided, together with the models built, in a software container, allowing full reproducibility, and representing by itself a contribution for the community.
successes, the full usefulness of human GSMMs lies on the ability to create methods for 23 the phenotype simulation of distinct cell types. During the last decade, a few methods 24 have been proposed towards this aim, integrating generic models with omics data. Here, 25 data are used to generate constraints refining GSMMs, to predict the phenotype of cell 26 types, as it is the case with iMAT [14] and GIMME [16] . However, these only allow the 27 phenotype prediction for conditions for which data was measured, and have revealed 28 less convincing results when tested in prediction benchmarks [17] . 29 An alternative lies in methods that create tissue-specific GSMMs, restricting the 30 metabolic portfolio of the original model (called template) to reactions occurring in that 31 cell type, as identified from omics data or biochemical knowledge/ literature. A number 32 of methods have been proposed in the last years to address this task. MBA [18] uses an 33 heuristic approach to prune the original set of reactions, based on evidences from 34 literature and data, and was first used to create an hepatocyte model. Similarly, a 35 variant of GIMME was used to create models for brain cells towards an improved 36 understanding of Alzheimer disease [19] . More recently, the INIT algorithm was applied 37 for the reconstruction of GSMMs for 69 cell types [11] , based on mixed integer-linear 38 programming, using proteomics and metabolomics data. The task-driven INIT (tINIT) 39 is an extension of the previous algorithm [20] that allows to define metabolic tasks that 40 the resulting models need to be able to achieve. mCADRE [21] and FASTCORE [22] 41 are based on the ideas of MBA, but reformulate the problem to make the algorithms 42 computationally more efficient, and thus have been used to reconstruct models in a 43 larger scale. A recent method, PRIME [23] , uses cell growth measurements, and their 44 correlations with gene expression, to filter the relevant reactions. 45 These methods have been used in a number of applications, many of which are 46 related to drug discovery research, mainly to identify metabolic targets that can inhibit 47 cancer cell growth. A first study built a generic cancer model [24] , using a variant of Still, in spite of these successful applications, no algorithm for tissue-specific 53 reconstruction has shown a consistent ability to generate accurate models, able to 54 provide phenotype predictions according to known metabolic behaviour, taken from 55 literature or available data. Also, the models provided by different methods and data 56 sources have shown a very high level of variability in some preliminary studies [26] , 57 which may suggest that an ensemble based approach might lead to better models. 58 Here, the most promising algorithms (MBA, tINIT, mCADRE and FASTCORE) 59 were used to reconstruct tissue-specific metabolic models for two case studies, 60 hepatocytes and a glioblastoma cell line, resorting to different data sources. The models 61 generated in each case were analyzed and compared in different perspectives.
62
A new algorithm to combine the set of obtained models was proposed and applied to 63 achieve a consensus metabolic model for each case study. The resulting models were 64 validated using knowledge about known metabolic tasks in liver and omics data not 65 used in the model building process (e.g. metabolomics and growth rates).
66

Methods
67
Tissue-specific reconstruction methods
68
The reconstruction of specific metabolic models is a process with four main steps 3. Build the core reaction sets, based on the assumptions described in Table 1 . In 77 this step, some additional configurations are required depending on the selected 78 algorithm. In this work, the metabolic tasks used in the tINIT algorithm were 79 retrieved from [20] . Additionally, a set of metabolites were set in mCADRE and 80 tINIT algorithms as described in the original publications [20, 21] . 
86
MBA
87
The Model-Building Algorithm (MBA) [18] reconstructs a tissue-specific metabolic 88 model from a generic model by integrating a variety of tissue-specific molecular data 89 sources. The first step of this algorithm is to infer, from the tissue-specific data, two 90 sets of reactions denoted as the core reactions (C H ) and reactions that have a moderate 91 probability to be carried out in the specific tissue (C M ). This division is made 92 according to the accuracy level of the input data. In general, the C H set includes 93 human-curated tissue-specific pathways and the C M set includes reactions certified by 94 molecular data. The aim of this method is to find the most parsimonious tissue-specific 95 consistent model, which includes all the tissue-specific high-probability reactions (C H ), 96 The reconstruction of tissue-specific metabolic models has four main steps: collect data; convert scores from gene to reaction level; build the core reactions set and run the selected algorithm.
a maximal number of moderate probability reactions (C M ) and a set of additional
97
reactions from the generic model that are required for gap filling, using a greedy 98 heuristic search that is based on iteratively pruning reactions from the generic model.
99
tINIT 100
The task-driven Integrative Network Inference for Tissues (tINIT) [20] applied to integrate different types of "omics" data through the core set compilation by 141 the user, and there is no need to define parameters except the flux threshold , which is 142 used to guarantee the required minimum flux.
143
Omics data sources
144
Transcriptomics are, certainly, the most widely available type of omics data. Using
145
DNA microarrays or RNA-sequencing allows the quantification of gene expression levels 146 in different conditions [27, 28] . However, mRNA molecules are not always translated 147 into proteins [29] , and therefore the amount of protein produced depends on the gene 148 expression and the current state of the cell. Thus, the knowledge about the amounts of 149 proteins in the cell, provided by proteomics data [30] , is of foremost relevance. These 150 data can confirm the presence of proteins and quantify the amount of proteins within a 151 cell.
152
The input data used by the reconstruction algorithms present in our framework were 153 retrieved from the Human Protein Atlas (HPA) [31] and Gene Expression Barcode 154 (GEB) [32] databases. The information collected from HPA is scored as "supportive" or 155 "uncertain", depending on the similarity in immunostaining patterns and consistency 156 with protein/gene characterization data. For the present study, only the data classified 157 as "supportive" was used. Moreover, after the conversion of Ensemble gene identifiers to 158 gene symbols, duplicated genes with different evidence levels were removed.
159
Regarding the GEB data, the conversion to gene expression levels was done 160 considering the average level of probe sets for each gene. The mapping between probe 161 sets and gene symbols was performed using the library "hgu133plus2.db" from
162
Bioconductor. Besides these two data sources, the reaction sets described in [18] were 163 used in the reconstruction of the hepatocytes metabolic model, one of the case studies 164 in this work.
165
The context-specific reconstruction methods use different formats of input data.
166
Specifically, MBA uses two sets of reactions, where each reaction has High or Moderate 167 probability to be in the final model, while mCADRE and FASTCORE expect only one 168 set of reactions as input. In tINIT, each reaction from the template metabolic model used in mCADRE and FASTCORE methods were built considering the union of "High" 178 and "Moderate" gene evidences from HPA, or gene expression evidence greater or equal 179 to 0.5 from GEB, through the GPR association present in the template model. Table 1 summarizes the assumptions used to create the input data sets for each 181 algorithm. Applying these transformation rules is possible to adapt different input data 182 sources, such as HPA, GEB and C H and C M sets, for all methods.
180
183 Table 1 . Core sets used as input data.
This table summarizes the assumptions and thresholds used to create the sets used as inputs by the different algorithms.
Consensus algorithm
184
A consensus metabolic model can be reconstructed based on models obtained by the 185 combination of different algorithms and data sources. The main idea is to build a model 186 starting with the reactions present in most of the models, and iteratively append a set 187 of reactions to the final model so that it will be able to perform all the metabolic tasks 188 given as input to the algorithm.
189
Assuming a set of N algorithms is run with a set of M different input data 190 configurations, we have N × M possible models. Based on these models, the proposed 191 consensus algorithm consists on four main steps: The consensus algorithm here proposed, together with the set of previous algorithms 218 described above, were implemented in the Java language by the authors in an integrated 219 platform to enable comparison of their results. The code is available in GitHub 220 repository (https://github.com/saragcorreia/consensus tsmm). Moreover, a Docker 221 image are available in the repository Docker Hub (saracorreia/consensus tsmm/), with 222 all source code, scripts, data and models, for each of the case studies, allowing to fully 223 reproduce the results of this study. These resources represent, by themselves, a 224 contribution of this work, as they make available in a single platform a set of algorithms 225 to reconstruct tissue-specific models that were previously hard to compare since some already published metabolic models [21, 23] .
235
About 78% of the liver tissue is formed by hepatocyte cells that are the principal site 236 of the metabolic conversions underlying the diverse physiological functions of the 237 liver [33] . A consensus hepatocyte metabolic model was here reconstructed using 238 different omics data sources and algorithms, also evaluating the effects that each of 239 those data types has in the resulting tissue-specific model.
240
The hepatocytes metabolic models were generated using Recon 1 and combining 241 different data sources (GEB, HPA and the C H and C M sets from [18] ). The four 242 algorithms described above (MBA, tINIT, mCADRE and FASTCORE) were used, 243 leading to the creation of twelve distinct metabolic models were obtained.
244
Following the same approach, eight metabolic models were reconstructed for U-251 245 glioblastoma cell lines, considering HPA and GEB as data sources and the same four 246 algorithms previously mentioned. Glioblastoma (GBM), also known as astrocytoma 247 grade IV, is the most common and aggressive type of brain cancer in adults [34] .
248
Despite the advances in the study of this type of cancer, it remains largely incurable.
249
The consensus algorithm described in the previous section was applied to reconstruct 250 consensus metabolic models for both hepatocytes and U-251 glioblastoma cell lines. In 251 each case, this algorithm took as input the models created using the different algorithms 252 and data sources, as described above.
253
The consensus models generated in this work are provided in the Systems Biology
254
Markup Language (SBML) format as supporting information.
255
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Data sources and template model (Fig 3A; upper row) . The numbers are further 267 dramatically reduced if we consider only moderate or high levels of evidence (Fig 3 B   268 and C;upper row). Analyzing the reaction evidence levels in this case, the overlap of reactions that support 272 the inclusion in the tissue-specific model is around of 97% and 99% for HPA and GEB, 273 respectively (Fig 3A; lower row) . However, if we take into account the expression 274 evidence levels, the number of reactions with the same evidence level is surprisingly low 275 (Fig 3 B and C; lower row) . The lower overlap in the high and moderate sets of 276 reactions considering the cutoffs of "High"/ 0.9 and "Medium"/ 0.5 from data retrieved 277 from HPA/GEB can have a significant impact in the resulting models, independently of 278 the used algorithm.
279
Hepatocytes tissue-specific metabolic models
280
For the hepatocytes, the twelve metabolic models built in this work have between 1178 281 and 2139 reactions, as shown in Table 2 . A more detailed comparison between the 282 models reconstructed using the same algorithm or the same data source is available in 283 Fig 4, A and B To analyze the influence of different algorithms or data sources in the final models, 290 we calculated the percentage of overlapping reactions. These values show that the same 291 input data under different algorithms produces metabolic models with lower variance,
292
i.e with more overlap, than using the same algorithm for different omics data sources.
293
Furthermore, the mean of reactions that belong to all models of the same algorithm is 294 around 49%, and around 60% when the models are grouped by data source. Again, the 295 variability of the final results seems to be dominated by the data source factor. This can 296 also be observed performing a hierarchical clustering of the models (Fig 5 A) . A set of metabolic tasks known to occur in hepatocytes was previously presented by 298 Gille et al. [35] . Some of these tasks are impossible to satisfy using Recon 1 for the 299 phenotype simulations, because these include metabolites which are not present in the 300 model. Thus, these tasks will not be considered in the validation process. We have also 301 removed disease related tasks, as these do not configure the regular behaviour of 302 hepatocytes.
303
The Recon 1 template model is able to satisfy 281 of the remaining 363 metabolic 304 functions tested, and therefore this number represents the maximum that may be 305 achieved by any model derived from Recon 1 as the template. This set of 281 metabolic 306 tasks was used to validate each hepatocytes metabolic model, running simulations with 307 it to assess if each task could be satisfied.
308
The relationship between the model size and the number of satisfied tasks for all 309 reconstructed models is presented in Fig 5 B . FASTCORE is able to produce consistent 310 models independently of the input data. tINIT also has a significant percentage of valid 311 tasks when the data source is HPA. However, generically, the number of satisfied 312 metabolic tasks is very low compared with the performance of the template model 313 Recon 1.
314
Using the consensus algorithm proposed in this work, we reconstructed the final 315 hepatocytes consensus model based on the twelve partial models. The consensus model 316 has 1859 reactions satisfying the whole set of 281 metabolic tasks (Fig 5 B) . So, this 317 model is able to perform the same tasks as Recon 1, while keeping only about 50% of 318 the reactions.
319
Glioblastoma tissue-specific metabolic models
320
Following a similar pipeline to the one described for hepatocytes, eight models were 321 reconstructed for the glioblastoma U-251 cell line. The set of algorithms was the same, 322 while the data sources were limited to HPA and GEB, since no pre-defined lists of 323 reactions were available in this case. Fig 6 shows the overlap of the resulting models 324 from the different algorithms, when each of the omics data source was considered. Comparing the models reconstructed with the same data source, tINIT and MBA 326 algorithms produce models with a higher number of exclusive reactions, i.e., reactions 327 present in a single model. The number of reactions shared by all models for each data 328 source is similar, 913 and 804 for HPA and GEB, respectively. However, the intersection 329 of these two sets is only of 577 reactions. ones generated by HPA and GEB are also of a similar size.
336
One of the hallmarks of cancer is the ability that cancer cells have to proliferate. To 337 address this issue, FBA simulations were done to test the growth rate (through 338 maximization of the biomass flux) of each model. The biomass equation was collected 339 from the Recon 2 metabolic model and the RPMI-1640 medium [36] has been 340 considered in all simulations.
341
As a result, none of the models was able to produce biomass which indicates there 342 are gaps in the models towards the production of some biomass precursor metabolites 343 (essential for growth). We then tested how many biomass precursors could be produced 344 by each metabolic model, by adding artificial drain reactions to excrete each biomass 345 precursor and simulating the maximization of these reactions. Table 3 presents the 346 number of biomass precursors produced by each of the U-251 metabolic models.
347
The U-251 model generated by the tINIT algorithm using HPA has the highest 348 number of biomass precursors satisfied. This was expected since this model has 349 approximately 500 more reactions than the remaining models.
350
Given these results, the reconstruction of a single, unified and global U-251 351 metabolic model capable of sustaining cell growth is desirable. This model must be able 352 to carry flux on the biomass reaction, to allow to simulate the proliferation of cells,
353
predicting their growth rate.
354
As before, the consensus U-251 metabolic model was built considering all previously 355 reconstructed models by different methods and data sources. The process starts with the reconstruction of the partial models (pM odel i i ∈ 1, ..8) as described in the
357
Methods section.
358
In this case, the tasks will be defined as the production of biomass precursors. So,
359
we checked how many biomass precursors each partial model was able to produce. biomass precursors between two partial models (toDel i ) are appended to the LRS in the 371 Fig 8. A) Number of reactions (green bars) and number of biomass precursors that can be produced (orange bars) by the pM odels. The pM odel 8 was ignored since pM odel 7 does not produce any of the biomass precursors. B) Overlap of metabolic models. The PRIME and mCADRE models are available in the methods publication articles. The consensus model is our model, reconstructed during this study.
next iteration. The process ends with the processing of pM odel 0 , in this case the full 372 Recon 1 model.
373
The final consensus model obtained is composed of 922 genes, 1376 metabolites and 374 1457 reactions. This model is able to simulate the biomass production, through FBA, 375 using the RPMI-1640 medium [36] . The flux rate for biomass equation is around 376 0.0291 mmol/gDW/hr. Although the lower biomass flux rate, when compared with the 377 original model Recon 1 (0.084 mmol/gDW/hr), this process is able to achieve a final 378 consensus model based in all previous models capable to simulate the biomass 379 production.
380
Other tissue-specific metabolic models 381 Glioblastoma GSMMs were already reconstructed in previous studies [21, 23] . The 382 glioblastoma tumor cells and U-251 cell line GSMMs reconstructed by mCADRE and 383 PRIME algorithms were used to perform a comparison with our consensus model. The 384 overlap between these glioblastoma metabolic models is provided in Fig 8 B) .
385
Analyzing the model obtained by PRIME, we verified that the Recon 1 template 386 model used by the algorithm is not the original model, but an extended version which 387 has 46 extra reactions. These reactions are essentially for excretion of cytosol 388 metabolites which can lead to significant differences in the phenotype simulation results. 389 The models PRIME, mCADRE and Consensus are composed by 1952, 1131 and 1457 390 reactions, respectively.
391
To further validate our model we decided to perform additional phenotype 392 simulations, using the methods pFBA [5] , iMAT [37] , GIMME [38] and E-Flux [39] , 393 which are able to integrate omics data to improve prediction results. Transcriptomics 394 data published by Gholami et al. [40] , which were not used for model reconstruction,
395
were used as inputs. Experimental flux values published by Jain et al. [41] were used to 396 compare with the flux exchange rates predicted by the different methods and the 397 normalized prediction errors were calculated using the equation: Table 4 .
405 Table 4 . The normalized prediction errors, associated with the simulation methods pFBA, GIMME, E-Flux and iMAT, for U-251 model reconstructed by PRIME and consensus algorithm. pFBA E-Flux GIMME iMAT The best combinations have a normalized error around 0.7-0.8. The one reaching a 406 lower prediction error was obtained with our consensus U-251 metabolic model using 407 the iMAT simulation method. Although no definitive conclusions may be taken from 408 these results, this contributes to provide a higher confidence in our consensus model.
409
Critical genes
410
The validation of metabolic models is a hard task when fluxomics data are not available. 411 So, further tests were done to check if the consensus metabolic model has a better 412 phenotype prediction capability than the global model Recon 1.
413
As a final test, we calculated the predicted critical genes of both models (our 414 consensus glioblastoma model vs the Recon 1). We considered to be critical (or 415 essential) the genes that inhibit growth when they are removed from the model. We 
432
• The SLC5A7 gene encodes a high-affinity choline transporter. Choline is used for 433 the synthesis of essential lipid components of cell membranes [44] . • The PTDSS1 gene encodes phosphatidylserine synthase 1 (PSS1) which is 455 involved in the production of phosphatidylserine. This gene is involved in a patent 456 related to the development of a molecular-based method of cancer diagnosis and 457 prognosis. Together with five others genes, the PTDSS1 has a higher expression in 458 tumor samples when compared with control samples [56] .
459
• The CTPS gene encodes an enzyme responsible for the conversion of UTP
460
(uridine triphosphate) to CTP (cytidine triphospate). The development of 461 methods and pharmaceutical compositions to inhibit the lymphocyte proliferation 462 through the CPTS1 inhibitors has been protected by a patent [57] .
463
• The NME2 / NME1 genes were identified as potential tumor suppressors, which 464 reduce the tumor progression and proliferation [58] . Thus, it was unexpected that 465 these genes were essential for the metabolic model. To understand this result, we 466 did a deep analysis of the reactions where these genes are involved. The two genes 467 regulate the activation of nucleoside-diphosphate kinase reactions in the nucleus. 468 These reactions are responsible to produce essential metabolites present in 469 biomass equation, namely Deoxyguanosine triphosphate (dGTP), Deoxycytidine 470 triphosphate (dCTP), Deoxyadenosine triphosphate (dATP) and Deoxythymidine 471 triphosphate (dTTP). These metabolites are used in cells for DNA synthesis.
472
Conclusions
473
In this work, a critical assessment of the most important methods for the reconstruction 474 of tissue-specific metabolic models was performed. Moreover, the consistency of 475 information across important omics data sources was analyzed and these data were used 476 to verify the impact of such differences in the final metabolic models generated by each 477 method. The results show that metabolic models obtained depend more on the data 478 sources used as inputs than on the algorithms used for the reconstruction. To validate 479 the performance of the obtained metabolic models regarding phenotype prediction, a set 480 of metabolic functions was tested for each metabolic model. Generically, the number of 481 satisfied metabolic functions was surprisingly low. This shows that existing methods for 482 the reconstruction of tissue-specific metabolic models, based on a single omics data 483 source, are not enough to generate high quality metabolic models.
484
Here, a strategy to build a final metabolic model using the combination of generated 485 models through different algorithms and data sources was presented. This process 486 shows that with a similar number of reactions, it is possible to achieve a final model 487 capable of satisfying all possible metabolic tasks.
488
A variant of the previous method was also used to reconstruct a consensus model of 489 glioblastoma cell lines. The method was able to find a consistent model, able to sustain 490 growth of cancer cells, with around half of the reactions from the template model. The 491 consensus model showed a good predictive ability of flux distributions, combined with 492 further omics data, competitive with previous approaches. Also, it allowed to uncover 493 several candidate essential genes of glioblastoma cell lines, a few of which have been 494 previously identified in literature as relevant targets or biomarkers.
495
Overall, the method here proposed provides an additional tool in modeling efforts in 496 cancer research and drug development, providing a way to build more robust metabolic 497 models given available omics data sources and phenotypic data. 
